Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The absence of intrarenal ACE protects against hypertension
Romer A. Gonzalez-Villalobos, … , Kenneth E. Bernstein, Alicia A. McDonough
Romer A. Gonzalez-Villalobos, … , Kenneth E. Bernstein, Alicia A. McDonough
Published April 24, 2013
Citation Information: J Clin Invest. 2013;123(5):2011-2023. https://doi.org/10.1172/JCI65460.
View: Text | PDF
Research Article

The absence of intrarenal ACE protects against hypertension

  • Text
  • PDF
Abstract

Activation of the intrarenal renin-angiotensin system (RAS) can elicit hypertension independently from the systemic RAS. However, the precise mechanisms by which intrarenal Ang II increases blood pressure have never been identified. To this end, we studied the responses of mice specifically lacking kidney angiotensin-converting enzyme (ACE) to experimental hypertension. Here, we show that the absence of kidney ACE substantially blunts the hypertension induced by Ang II infusion (a model of high serum Ang II) or by nitric oxide synthesis inhibition (a model of low serum Ang II). Moreover, the renal responses to high serum Ang II observed in wild-type mice, including intrarenal Ang II accumulation, sodium and water retention, and activation of ion transporters in the loop of Henle (NKCC2) and distal nephron (NCC, ENaC, and pendrin) as well as the transporter activating kinases SPAK and OSR1, were effectively prevented in mice that lack kidney ACE. These findings demonstrate that ACE metabolism plays a fundamental role in the responses of the kidney to hypertensive stimuli. In particular, renal ACE activity is required to increase local Ang II, to stimulate sodium transport in loop of Henle and the distal nephron, and to induce hypertension.

Authors

Romer A. Gonzalez-Villalobos, Tea Janjoulia, Nicholas K. Fletcher, Jorge F. Giani, Mien T.X. Nguyen, Anne D. Riquier-Brison, Dale M. Seth, Sebastien Fuchs, Dominique Eladari, Nicolas Picard, Sebastian Bachmann, Eric Delpire, Janos Peti-Peterdi, L. Gabriel Navar, Kenneth E. Bernstein, Alicia A. McDonough

×

Figure 2

The absence of kidney ACE reduces both renal Ang II accumulation and sodium and water retention in response to Ang II infusion.

Options: View larger image (or click on image) Download as PowerPoint
The absence of kidney ACE reduces both renal Ang II accumulation and sod...
(A) Kidney Ang II content of wild-type and ACE 10/10 mice after 2 weeks of Ang II infusion (400 ng/kg/min via minipump). Ang II concentration was measured by radioimmunoanalysis. n = 6–12 per group. (B) Urine and (C) sodium output of wild-type and ACE 10/10 mice during chronic Ang II infusion. Mice were housed individually in metabolic cages, with free access to food and water. Results are expressed as daily averages. n = 8–10 per group. *P < 0.05, ***P < 0.001. Values represent individual measurements and mean ± SEM.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts